NuvoAir provides a digital care platform for people with asthma and COPD. It combines at-home devices, real-time health data, and virtual visits with a dedicated care team to help patients manage their respiratory conditions. Patients or clinics subscribe to the service and pay for ongoing access to the technology and care services. The platform works by collecting data from devices and user input, sharing it with clinicians, and enabling remote consultations so doctors can make informed treatment decisions. NuvoAir differentiates itself by offering end-to-end support that includes hardware, software, and a care team, along with a free clinic trial and nationwide availability in all 50 U.S. states. This approach has yielded measurable results, such as fewer urgent consultations and strong user retention. The company aims to improve respiratory health outcomes by enabling proactive, data-driven care for patients, providers, and researchers.
Company Size
51-200
Company Stage
Series A
Total Funding
$28.2M
Headquarters
Boston, Massachusetts
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?